CH
SKYE icon

CVI Holdings’s Skye Bioscience SKYE Stock Holding History

CVI Holdings’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$5.44M Buy
+84,967
New +$8.07M 4.69% 3

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
ACM
Altium Capital Management New York $47.5M AUM 115.72% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

CVI Holdings's SKYE Position: Q2 2024 in Review

CVI Holdings opened a new position in Skye Bioscience (SKYE) in Q2 2024: 84,967 shares worth $5.44M. The stake represents 4.69% of the portfolio and ranks #3 among its holdings.

56 funds tracked by Wall St. Rank hold SKYE as of Q2 2024.

  • CVI Holdings held 84,967 shares of Skye Bioscience worth $5.44M as of Q2 2024.
  • Skye Bioscience was a new CVI Holdings position in Q2 2024.
  • Skye Bioscience made up 4.69% of CVI Holdings's portfolio in Q2 2024, its #3 holding.
  • 56 funds tracked by Wall St. Rank held Skye Bioscience as of Q2 2024.

Based on CVI Holdings's 13F filing for Q2 2024, filed 15 Aug 2024.